Skip to main content
Midas Edge

CRYO CELL INTERNATIONAL INC

For the period ended Nov 30, 2024. Filed Feb 28, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 28, 2025

CCEL$4.92+0.5%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The consolidated financial statements and supplementary data listed in the accompanying Index to Consolidated Financial Statements are attached as part of this report.

The following consolidated financial statements of Cryo-Cell International, Inc. are included in Item 8:

Report of Independent Registered Public Accounting Firm42
Consolidated Balance Sheets as of November 30, 2024 and 202344
Consolidated Statements of Operations For the Fiscal Years Ended November 30, 2024 and 202345
Consolidated Statements of Cash Flows For the Fiscal Years Ended November 30, 2024 and 202346
Consolidated Statements of Stockholders’ Deficit For the Fiscal Years Ended November 30, 2024 and 202347
Notes to Consolidated Financial Statements48

All other schedules for which provision is made in the applicable accounting regulations of the Securities and Exchange Commission are not required under the related instructions, are already included in the Notes to Consolidated Financial Statements included under this Item 8 or are inapplicable, and therefore have been omitted.

7000 Central Parkway NE404.420.5691
Suite 1000wipfli.com
Atlanta, GA 30328
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.